APA (7th ed.) Citation

EM, C., PD, D., JM, S. S., R, G. L., G, L., S, C., . . . J, G. B. (2026). Post-recurrence management of malignant glial brain tumors: Therapeutic strategies, evidence and limitations, palliative care, terminal sedation, and end-of-life considerations. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04401-w

Chicago Style (17th ed.) Citation

EM, Corrales-García, et al. "Post-recurrence Management of Malignant Glial Brain Tumors: Therapeutic Strategies, Evidence and Limitations, Palliative Care, Terminal Sedation, and End-of-life Considerations." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026. https://doi.org/10.1007/s12094-026-04401-w.

MLA (9th ed.) Citation

EM, Corrales-García, et al. "Post-recurrence Management of Malignant Glial Brain Tumors: Therapeutic Strategies, Evidence and Limitations, Palliative Care, Terminal Sedation, and End-of-life Considerations." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026, https://doi.org/10.1007/s12094-026-04401-w.